BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17434719)

  • 1. Adjuvant chemoradiation for gastric cancer: experience in the Chinese population.
    Tsang WK; Leung SF; Chiu SK; Yeung WW; Ng EK; Yeo W; Lam KC; Chiu PW; Ma BB; Kwan WH; Chan AT
    Clin Oncol (R Coll Radiol); 2007 Jun; 19(5):333-40. PubMed ID: 17434719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of adjuvant chemoradiotherapy after a radical gastrectomy and a D2 node dissection for gastric adenocarcinoma.
    Leong CN; Chung HT; Lee KM; Shakespeare TP; Mukherjee RK; Wong LC; Lu JJ; Tey J; Lim R; So JB; Back MF
    Cancer J; 2008; 14(4):269-75. PubMed ID: 18677137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant chemoradiation for resected gastric cancer: a 10-year experience.
    Chang AT; Ng WT; Law AL; Ku KM; Lee MC; Lee AW
    Gastric Cancer; 2011 Mar; 14(1):63-71. PubMed ID: 21327926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant therapy for elderly patients with resected gastric adenocarcinoma: population-based practices and treatment effectiveness.
    Hoffman KE; Neville BA; Mamon HJ; Kachnic LA; Katz MS; Earle CC; Punglia RS
    Cancer; 2012 Jan; 118(1):248-57. PubMed ID: 21692071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative chemoradiation for resected gastric cancer--is the Macdonald Regimen Tolerable? a retrospective multi-institutional study.
    Kundel Y; Purim O; Idelevich E; Lavrenkov K; Man S; Kovel S; Karminsky N; Pfeffer RM; Nisenbaum B; Fenig E; Sulkes A; Brenner B
    Radiat Oncol; 2011 Sep; 6():127. PubMed ID: 21958692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrence patterns after radical gastrectomy for gastric cancer: prognostic factors and implications for postoperative adjuvant therapy.
    Schwarz RE; Zagala-Nevarez K
    Ann Surg Oncol; 2002 May; 9(4):394-400. PubMed ID: 11986192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival.
    Chakravarthy A; Abrams RA; Yeo CJ; Korman LT; Donehower RC; Hruban RH; Zahurek ML; Grochow LB; O'Reilly S; Hurwitz H; Jaffee EM; Lillemoe KD; Cameron JL
    Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1089-96. PubMed ID: 11072167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.
    Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC
    Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The toxicity and outcomes of continuous 5-fluorouracil/cisplatin-based chemotherapy followed by chemoradiation in patients with resected high-risk gastric cancer: results of a single institute.
    Yakir R; Luna K; Marc W; Tamar S; Avraham R; Ayala H
    Ann Acad Med Singap; 2008 Mar; 37(3):200-4. PubMed ID: 18392298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative intraperitoneal 5-fluoro-2'-deoxyuridine added to chemoradiation in patients curatively resected (R0) for locally advanced gastric and gastroesophageal junction adenocarcinoma.
    Cohen DJ; Newman E; Iqbal S; Chang RY; Potmesil M; Ryan T; Donahue B; Chandra A; Liu M; Utate M; Hiotis S; Pachter LH; Hochster H; Muggia F
    Ann Surg Oncol; 2012 Feb; 19(2):478-85. PubMed ID: 21769462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoradiation for resectable gastric cancer.
    Xiong HQ; Gunderson LL; Yao J; Ajani JA
    Lancet Oncol; 2003 Aug; 4(8):498-505. PubMed ID: 12901965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant chemoradiotherapy with or without intraoperative radiotherapy for the treatment of resectable locally advanced gastric adenocarcinoma.
    Zhang Q; Tey J; Peng L; Yang Z; Xiong F; Jiang R; Liu T; Fu S; Lu JJ
    Radiother Oncol; 2012 Jan; 102(1):51-5. PubMed ID: 22178689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adjuvant therapy after curative resection with D2 lymphadenectomy for gastric cancer: results of a prospective clinical trial].
    Markelis R; Endzinas Z; Kiudelis M; Grizas S; Pundzius J; Saladzinskas Z; Juozaityte E; Inciūra A; Pranys D; Maleckas A
    Medicina (Kaunas); 2009; 45(6):460-8. PubMed ID: 19605966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole abdominal field versus standard field radiotherapy plus concomitant and adjuvant chemotherapy for patients with locally advanced gastric cancer.
    Orhan O; Eroglu C; Kaplan B; Ucar K; Altinbas M; Ozkan M; Unal D; Yildiz OG; Soyuer S
    J Radiat Res; 2011; 52(2):168-75. PubMed ID: 21343682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformal radiotherapy in the adjuvant treatment of gastric cancer: Review of 82 cases.
    Kassam Z; Lockwood G; O'brien C; Brierley J; Swallow C; Oza A; Siu L; Knox JJ; Wong R; Cummings B; Kim J; Moore M; Ringash J
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):713-9. PubMed ID: 16626887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Outcomes and Prognostic Factors in Gastric Carcinoma Patients with Curative Surgery Followed by Adjuvant Treatment: Real-World Scenario.
    Kapoor R; Dracham CB; G Y S; Khosla D; Dey T; Elangovan A; Madan R; Yadav BS; Kumar N
    J Gastrointest Cancer; 2021 Jun; 52(2):616-624. PubMed ID: 32535755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraoperative radiotherapy for the treatment of resectable locally advanced gastric adenocarcinoma: topography of locoregional recurrences and long-term outcomes.
    Calvo FA; Sole CV; Obregón R; Gómez-Espí M; González-San Segundo C; González-Bayón L; Alvarez E; García-Sabrido JL
    Clin Transl Oncol; 2013 Jun; 15(6):443-9. PubMed ID: 23143948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach.
    Kim S; Lim DH; Lee J; Kang WK; MacDonald JS; Park CH; Park SH; Lee SH; Kim K; Park JO; Kim WS; Jung CW; Park YS; Im YH; Sohn TS; Noh JH; Heo JS; Kim YI; Park CK; Park K
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1279-85. PubMed ID: 16099596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative adjuvant chemoradiation therapy for patients with resected gastric cancer: intergroup 116.
    Schwarz RE
    J Clin Oncol; 2001 Mar; 19(6):1879-80. PubMed ID: 11251020
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.